VITA, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 10.875
EU - Europa 4.700
AS - Asia 3.722
SA - Sud America 495
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 3
Totale 19.863
Nazione #
US - Stati Uniti d'America 10.450
CN - Cina 1.831
RU - Federazione Russa 1.326
SG - Singapore 1.003
DE - Germania 637
IT - Italia 606
BR - Brasile 444
SE - Svezia 403
GB - Regno Unito 395
CA - Canada 384
UA - Ucraina 374
HK - Hong Kong 305
FR - Francia 260
PL - Polonia 217
FI - Finlandia 197
TR - Turchia 136
KR - Corea 124
VN - Vietnam 115
IE - Irlanda 102
IN - India 52
NL - Olanda 40
BE - Belgio 37
MX - Messico 31
CZ - Repubblica Ceca 30
JP - Giappone 30
ES - Italia 21
EU - Europa 20
AR - Argentina 19
ZA - Sudafrica 18
BD - Bangladesh 17
IR - Iran 17
IQ - Iraq 14
UZ - Uzbekistan 14
VE - Venezuela 10
EE - Estonia 8
MA - Marocco 8
CH - Svizzera 7
EC - Ecuador 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
GR - Grecia 6
ID - Indonesia 6
LT - Lituania 6
PK - Pakistan 6
TN - Tunisia 6
BW - Botswana 5
DK - Danimarca 5
KG - Kirghizistan 5
AZ - Azerbaigian 4
BG - Bulgaria 4
GE - Georgia 4
KE - Kenya 4
KZ - Kazakistan 4
PE - Perù 4
SA - Arabia Saudita 4
CL - Cile 3
DZ - Algeria 3
IL - Israele 3
JO - Giordania 3
NZ - Nuova Zelanda 3
PA - Panama 3
TW - Taiwan 3
AT - Austria 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
PH - Filippine 2
PS - Palestinian Territory 2
AL - Albania 1
AM - Armenia 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
GL - Groenlandia 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
NP - Nepal 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
Totale 19.863
Città #
Fairfield 977
Jacksonville 956
Woodbridge 852
Ashburn 823
Chandler 711
Houston 646
Ann Arbor 590
Singapore 495
Wilmington 448
Seattle 436
Boardman 382
Nanjing 361
Cambridge 310
Hong Kong 305
Beijing 241
Toronto 231
Dallas 193
Dearborn 187
Kraków 182
Los Angeles 179
San Mateo 155
The Dalles 140
Nanchang 137
Seoul 123
Columbus 120
Lawrence 120
Princeton 120
Tongling 120
New York 115
Lachine 114
Istanbul 98
Ogden 94
Moscow 86
Dublin 84
Düsseldorf 82
London 80
Shenyang 80
Bremen 77
Buffalo 74
Helsinki 69
Milan 62
Shanghai 61
Hebei 60
Jiaxing 51
Kunming 51
Munich 51
São Paulo 47
Chicago 45
Guangzhou 39
Tianjin 37
Jinan 36
San Diego 36
Brussels 35
Ho Chi Minh City 32
Warsaw 32
Wuhan 29
Hefei 28
Stockholm 28
Hanoi 27
Menlo Park 27
Phoenix 27
Tokyo 27
Montreal 26
Changsha 25
Redwood City 25
Council Bluffs 24
Orange 24
Brooklyn 23
Poplar 23
Chennai 22
Denver 22
Philadelphia 22
Zhengzhou 22
Leawood 21
Venezia 21
Boston 20
Brno 19
Orem 19
Rome 18
Santa Clara 17
Verona 17
Auburn Hills 16
Belo Horizonte 16
Kocaeli 15
Lanzhou 15
Manchester 15
Ankara 14
Detroit 14
Hangzhou 14
Johannesburg 14
Rio de Janeiro 14
Washington 14
Falls Church 13
Atlanta 12
Brasília 12
Changchun 12
Mexico City 12
Tashkent 12
Ardabil 11
Norwalk 11
Totale 13.127
Nome #
Evidenza di anticorpi anti-gliadina e transglutaminasi in sieri di cani affetti da enterite linfoplasmacellulare 316
A Proteomic Study on Donkey Milk 283
Modulation of human cytidine deaminase by specific aminoacids involved in the intersubunit interactions. 265
PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a Central Italy population 253
Role of tyrosine 33 residue for the stabilization of the tetrameric structure of human cytidine deaminase 236
Studies of thermal stability in human cytidine deaminase 235
Functional properties of subunit interactions in human cytidine deaminase 230
Effects of Lyophilization and Use of Probiotics on Donkey’s Milk Nutritional Characteristics 230
Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1 230
Human placenta cytidine deaminase: a zinc metalloprotein 228
Human cytidine deaminase: understanding the catalytic mechanism 220
Bakers' yeast protease A. Purification and enzymatic and molecular properties. 220
Isoenzymatic forms of human cytidine deaminase 219
Delineation of the molecular mechanisms of nucleoside recognition by cytidine deaminase through virtual screening. 218
Site directed mutagenesis as a tool to understand the catalytic mechanism of human cytidine deaminase. 217
Studies on thermal stability of human cytidine deaminase 216
An Immunoenzyme Linked Assay (ELISA) for the Detection of Antibodies to Truncated Glycoprotein D (tgD) of Bovine Herpesvirus-1 209
Catabolite inactivation of bakers' yeast uridine nucleosidase. Isolation and partial purification of a specific proteolytic inactivase. 209
Uridine phosphorylase from Escherichia coli B. Enzymatic and molecular properties 208
A comparison of the enantioselectivities of human deoxycytidine kinase and human cytidine deaminase 207
Pyrimidine 5'-nucleotidase(s) of human erythrocytes: enzymatic and molecular characterization 203
Inactivation of uridine nucleosidase in yeast. Purification and properties of an inactivating protein. 202
CD38 in bovine lung: a multicatalytic NADase 201
Cytidine deaminase from two extremophilic bacteria: cloning, expression and comparison of their structural stability 199
A spectrophotometric method for the assay of pyrimidine 5'-nucleotidase in human erythrocytes 199
Nuclear matrix-associated NMN adenylyltransferase activity in human placenta 198
Antiviral activity of purine nucleoside analogs against bovine herpesvirus (BHV-1) and maedi visna virus (MVV) 196
Antioxidant Properties of Donkey Milk 196
Effect of dephosphorylation on donkey milk caseins 195
Rapid allele-specific PCR method for CDA 79A>C (K27Q) genotyping: a useful pharmacogenetic tool and world-wide polymorphism distribution. 195
Possible role of two phenylalanine residues in the active site of human cytidine deaminase 194
Evidence for an inhibitory effect exerted by yeast NMN adenylyltransferase on poly(ADP-Ribose) polymerase activity 193
Donkey’s milk caseins characterization 192
Diazepinone nucleosides as inhibitors of cytidine deaminase 192
Yolk formation and degradation during oocyte maturation in seabream Sparus aurata: involvement of two lysosomal proteinases 192
Bakers' yeast uridine nucleosidase is a regulatory copper containing protein. 192
Human placenta cytidine deaminase: Proton-linked enzyme activity and substrate binding 191
A comparative study of some properties of cytidine deaminase from Escherichia coli and chicken liver 191
Purification of human cytidine deaminase : Molecular and enzymatic characterization and inhibition by synthetic pyrimidine analogs 190
Unnatural enantiomers of 5-azacytidine analogues: syntheses and enzymatic properties 189
Studies on cysteine residues in the active site of human cytidine deaminase 188
Presence of a specific uridine 5'-monophosphate pyrophosphorylase in baker's yeast 188
Amino acid residues coordinating zinc atom in cytidine deaminase catalytic site 187
Further studies on intersubunit interactions in human cytidine deaminase 187
Cytidine deaminase from human spleen 186
Evidence of anti-gliadin and transglutaminase antibodies in sera of dogs affected by lymphoplasmacytic enteritis. 185
Protein fraction characterization of sheep milk from the Comisana breed 184
A proteomic approach for the characterization of donkey's milk protein fraction 183
NMN ADENYLYLTRANSFERASE FROM BULL TESTIS: PURIFICATION AND PROPERTIES 183
Amino-terminal protein transacetylase from wheat germ 182
NAD biosynthesis in human placenta: purification and characterization of homogeneous NMN adenylyltransferase 176
A one-step procedure for the purification of uridine phosphorylase from Escherichia coli. 176
The cytidine deaminase family: a review 175
Cytidine deaminase: a rapid method of purification and some properties of the enzyme from human placenta 173
Baker's yeast UMP: pyrophosphate phosphoribosyltransferase. Purification, enzymatic and kinetic properties. 172
Effect of Dephosphorylation on Donkey Milk Caseins 169
Cytidine dEaminase from human placenta 169
Isoenzymatic forms in human cytidine deaminase produced by two natural varianys of human cytidine deaminase gene. 168
Recent observations on the structure and properties of yeast NMN adenylyltransferase 168
A study of the action of nucleosides cytidine analogues on the replication of lentivirus Maedi/visna (MVV) 165
Uridine phosphorylase from Escherichia coli B: kinetic studies on the mechanism of catalysis. 163
Human cytidine deaminase: a three dimensional homology model of a tetrameric metallo-enzyme inferred from the crystal structure of distantly related dimeric homologue 161
A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice 159
Studies on cysteine residues involved in the active site of human cytidine deaminase 159
Ligand binding to proteins by equilibrium gel penetration 159
Involvement of oleuropein in (some) digestive metabolic pathways 159
Modulatory effect of oleuropein on digestive enzymes 156
Determinazione quantitativa di alcune sieroproteine nel latte di asina fresco, congelato e polverizzato 156
Recombinant human cytidine deaminase: expression, purification and characterization 155
Erythrocyte pyrimidine 5'-nucleotidase: HPLC assay, observation on the enzyme behaviour 155
Role of glutamate-67 in the catalytic mechanism of human cytidine deaminase 155
Possible role of two hydrophobic aminoacid residues in human cytidine deaminase 154
Human cytidine deaminase: structural requirements and proton effect on catalytic activity 153
Maedi-visna virus, a model for in vitro testing of potential anti-HIV drugs. 149
Studies on the protein fractions of donkey milk 147
NAD+-glycohydrolase isoforms in bovine lung 145
Inhibitory effect of spermidine and spermine on enzymatic activity of E.coli DHFR 145
A one-step procedure for the isolation of fructose 1,6-biphosphatase and fructose 1,6-biphosphatase aldolase from rabbit liver. 142
Cytidine deaminase from Escherichia coli B. Purification and enzymatic and molecular properties 142
Human cytidine deaminase: active site and antiviral activity 141
Maedi-visna virus: un modello per saggiare nuovi potenziali nucleosidi anti-HIV 141
Hydrophobic interactions at the active site of human cytidine deaminase 140
Attempts to produce a DNA vaccine against Bovine herpesvirus-1 (BHV-1) infections: preliminary investigations 140
NAD+ metabolism in lymphocytes of patients affected by B-cell chronic lymphocytic leukaemia 140
Studio dell'azione di nucleosidi citidina analoghi sulla replicazione del lentivirus maedi-visna 138
Inhibition of rabbit liver fructose 1,6-biphosphatase by AMP: effect of temperature and physiological concentrations of cations and anions. 138
NAD biosynthesys in human placenta: purification and characterization of homogeneous NMN adenylyltransferase 138
Purification and identification of alpha(s-1) and beta-caseins from asses milk 137
Involvment of cytidine deaminase in chronic B-lymphocytic leukemia 136
Aminoterminal acetylation of synthetic N-desacetyl thymosin a1 133
Evidence of anti-gliadine and anti-transglutaminase antibodies in serum of dogs with lymphoplasmacytic enteritis: correlation between serological data and pathology. 132
Intersubunit interactions in human cytidine deaminase 131
Deaza- and deoxyadenosine derivatives: synthesis and inhibition of animal viruses as human infectious models 130
Identification and quantitative lactoferrin determination in donkey milk 129
Partial characterization of eight human cytidine deaminase mutants 129
Studies on the active site of human cytidine deaminase by site-directed mutagenesis on its complementary DNA 126
Subunit dissociation in human cytidine deaminase 124
Nutritional Characteristics of donkey’s milk protein fraction 123
Site-directed mutagenesis on human cytidine deaminase gene 122
Studies on recombinant human cytidine deaminase 121
Totale 17.816
Categoria #
all - tutte 74.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.358 0 0 0 0 0 145 276 28 161 56 429 263
2021/20221.127 63 327 10 33 82 55 42 95 83 116 80 141
2022/20231.878 179 30 105 239 327 245 6 148 335 89 117 58
2023/20241.156 194 53 86 32 48 117 27 38 136 49 8 368
2024/20253.691 139 112 335 129 86 190 512 979 250 205 181 573
2025/20262.734 324 227 443 800 593 347 0 0 0 0 0 0
Totale 19.981